Profile
Chris Cargill is currently the President, CEO & Representative Director at Nxera Pharma Co., Ltd. since 2022.
He is also currently a Director at Nxera Pharma UK Ltd. since 2019.
Previously, he worked as a Director at Sosei R&D Ltd. Mr. Cargill completed his undergraduate degree at Monash University.
Chris Cargill active positions
| Companies | Position | Start |
|---|---|---|
| NXERA PHARMA CO., LTD. | Chief Executive Officer | 2022-03-23 |
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Director/Board Member | 2018-12-31 |
Former positions of Chris Cargill
| Companies | Position | End |
|---|---|---|
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
Training of Chris Cargill
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nxera Pharma Co., Ltd.
Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
- Stock Market
- Insiders
- Chris Cargill
















